Sign up
Log in
Molecular Partners shareholders approved CHF 1.13 million board pay cap for next term
Share
Listen to the news
Molecular Partners shareholders approved CHF 1.13 million board pay cap for next term
  • Molecular Partners held its annual general meeting on April 14, 2026 covering fiscal year 2025 reporting.
  • Shareholders adopted Annual Review, IFRS consolidated financial statements, and parent-company financial statements for 2025.
  • Advisory vote endorsed Compensation Report 2025.
  • Resolution passed to carry forward 2025 net loss of CHF 57,853,768, lifting accumulated loss carried forward to CHF 257,293,925.
  • Shareholders granted discharge to board members and management for 2025 actions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Molecular Partners AG published the original content used to generate this news brief on April 20, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.